The neuromuscular blocking effects of repeated bolus injections of pancuronium, or vecuronium, and of the continuous infim'nn of vecuTonhim have been compared in 36 patients by means of evoked twitch rirwinn Groups I and II received a loading dose (0.075 mg kg" 1 ) of pancuronium or vecuronium, respectively, followed by 0.015-mgkg do ch l hid recovered to 25% of control. Group 
Having demonstrated previously that, during prolonged surgical procedures, bolus injections of vecuronium were required as frequently as every 10 min, Buzello and Noeldge (1982) suggested that the continuous infusion of this drug would be a more appropriate technique with which to maintain a consistent degree of neuromuscular blockade. This mode of administration' has been studied in the present paper.
PATIENTS AND METHODS
Thirty-six patients (ASA I and II) undergoing gynaecological surgery were studied after informed consent had been obtained. Individuals younger than 20 and older than 60 years of age, and those with conditions or medications known to affect the pharmacodynamics of neuromuscular blocking drugs were excluded from the study. All patients were premedicated with atropine 0.01 mg kg"1 and atropine 0.01 mgkg" 1 injected i.v. if residual neuromuscular blockade was present at the end of the procedure. Neuromuscular transmission was monitored by recording the evoked twitch tension of the adductor pollicis muscle with the aid of a boomerang force displacement transducer (Walts, 1973) , further details of which have been described previously (Buzello and Noeldge, 1982) . Neuromuscular blockade was achieved with pancuronium, or vecuronium, depending on the random assignment of the patient to three different experimental programmes ( fig. 1 ): all patients received equal loading doses (0.075mgkg" 1 ) of pancuronium (group I) or vecuronium (groups II, III). In groups I and II, onefifth of the loading dose (0.015mgkg" 1 ) of pancuronium or vecuronium was repeated whenever neuromuscular transmission had recovered to 25% of control.
In group III an i.v. infusion of vecuronium 0.075 mg kg" 1 h" 1 was started at the time of injection of the loading dose (0.075mgkg~1). The rate of infusion was kept constant during the operation 
RESULTS
Patients in the three groups were comparable with respect to age, weight and duration of anaesthesia (table I) . The numbers of maintenance doses required in groups I and II are indicated in table II. The indices of neuromuscular blockade appropriate to the three different modes of administration are presented in tables III and IV. Figure 1 presents one individual tracing from each group. Within 1.5 to 6 min of the loading dose of either neuromuscular blocking drug, total neuromuscular blockade had been achieved in all patients, and there were no significant differences between the three groups. The duration of action of the loading dose of pancuronium (to 25% recovery of twitch tension (Dur 25 )) was of the order of 1 h (group I), being on average 2.6 times longer than that for vecuronium (group II). The maintenance doses of pancuronium acted for 3.5 times as long as those of vecuronium (Dur ItP 25)-Correspondingly, the total requirement for neuromuscular blocker to maintain neuromuscular transmission below 25% of control was three times greater with vecuronium. In group III (continuous infusion of vecuronium) the initial period of total blockade lasted for almost 1 h until an equilibrium was established at an average of 13% of control twitch tension. The degree of steady state blockade was subject to considerable individual variation, and in one patient the twitch tension stabilized at 60% of control.
At the end of surgery, seven out of 12 patients in group I had recovered spontaneously to 75% of the control twitch tension. In groups II and III, nine of 12 patients receiving vecuronium had recovered spontaneously to 75% of the control twitch tension. Among these patients, the shortest recovery times were seen with the repeated doses of vecuronium (table III, after repeated bolus injections of the same drug. D'Hollander and colleagues (1982) studied the effects of an infusion of vecuronium started 10 min after the injection i.v. of a0.07-mg kg" 1 loading dose and readjusted every 10 min for stable 90% twitch depression. The average maintenance dose (0.07 nig kg" 1 h" 1 ) and recovery time (22 min) obtained in their 40-60yr age group are consistent with the findings of the present study, where 11 out of the 12 patients were between 40 and 60 yr of age. However, the maintenance doses and the recovery times were subject to considerable individual variation. This was reflected also in our results and explains the poor response of one patient in group III to the constant infusion of vecuronium.
The recovery time of vecuronium has been reported previously not to correlate with its total cumulative dose (Buzello and Noeldge, 1982) . This finding has now been substantiated by the demonstration of identical recovery times following repeated bolus injections of 2 5% smaller doses (group II), and by the failure to demonstrate a correlation between the total dose infused and the recovery time (group III). Following the continuous infusion of vecuronium the mean recovery time was significantly longer than after its intermittent administration, suggesting that the two techniques generate different pharmacokinetic conditions. Sohn and colleagues (1982) proposed a three-compartment pharmacokinetic model where the uptake of the unchanged vecuronium was the main principle controlling the recovery of neuromuscular transmission, and it may be assumed that the infusion provides a more effective saturation of the third compartment than do intermittent injections. However, no pharmacokinetic data are available to support this view. In the study of Cronnelly and co-workers (1983) the infusion time (10 min) was too short to be comparable to the conditions of the present study. In contrast to our findings (table IV), d'Hollander and colleagues (1982) observed stable neuromuscular blockade 40 min after the injection of the loading dose, and only 9±4min elapsed from the end of infusion until recovery of 25% of control twitch tension. This difference is explained by the 10-min interval between loading dose and start of infusion and by the total dose of vecuronium which was 12-22% smaller than that in the present study.
The infusion of atracurium O^mgkg" 1 and O.SSmgkg-'h" 1 has been studied recently (d'Hollander et al., 1983) . The doses used were comparable to those of vecuronium in both their previous study and our present study. They all represent about 1.6 times the 90% blocking dose of either drug (Robertson et al., 1983) . The results with the infusion of atracurium are similar to the findings with the continuous administration of vecuronium except for the recovery time which was 7 min shorter with atracurium than with vecuronium. This difference may be a result of their different metabolic disposition. Hofmann elimination is the major metabolic pathway controlling the duration of action of atracurium (Hughes and Chappie, 1981) . In contrast, vecuronium undergoes redistribution and excretion with very little metabolic degradation (Sohn et al., 1982) . Apparently, under the conditions of continuous infusion, the metabolic pathways of atracurium are more effective in rapidly restoring neuromuscular transmission than those of vecuronium. Donati and Bevan (1982, 1983) re-evaluated the continuous infusion of suxamethonium. They denied the need for limitation of the total dose of suxamethonium, because neostigmine 1.25-2.5 mg i.v. reversed the phase II block in all patients. However, now that we have a new generation of non-depolarizing drugs available we do not see any further need for the infusion of suxamethonium.
Thus, the continuous infusion of vecuronium appears to be a satisfactory alternative to the incremental use of vecuronium or pancuronium. In procedures of l-3h duration the infusion technique provides surgical relaxation of a more consistent degree, and for a longer period of time, than does the repeated injection of either drug. The time required to stabilize neuromuscular blockade depends on the loading dose, on the time interval between injection of the loading dose and start of infusion, and on the rate of infusion. As a basic approach, for stable 90% block, the loading dose should be in the order of 1.5 times the cumulative ED W , and the same dose should be infused per hour. The infusion should be started within the first 10 min after the injection of the loading dose. 1 h~'. Con inyecciones repetidas de pancuronio (Grupo I) o de vecuronio (Grupo II), la duracion del bloqueo con rccuperacion del 2 5% fue de 64 y de 25 min, respectivamente. Dosis de mantenimiento tuvieron que administrarse cada 42 min con pancuronio y cada 12 min con vecuronio. El tiempo de recuperacion del 25% al 75% de la tension de contraccion de control fue de 44 min contra 12 min. La infusion continua de vecuronio (Grupo III) produjo un bloqueo neuromuscular constante con "n nivel promedio del 87% de la depresion de la contraccion. El periodo entre el fin de la infusion y la recuperaci6n al 25%, y entre la recuperacion al 25%y al 75%, vario en promedio de 20 a 26 min respectivamente. Dichos valores no tenian correlacion algiina con la dosis total de vecuronio infmoHn Con fines dinicos practicos, se sugiere una dosis equivalente a 1,5 vez el ED90 (0,07 mg kg" 1 ), seguida por una infusion en la minmn dosis cada hora. La infusion debena iniciarse dentro de los 10 min de la inyeccionde la dosis de carga.
